# Does medicinal cannabis work for depression, anxiety or PTSD? Our study says there’s no evidence > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/medicinal-cannabis-depression-anxiety-ptsd-evidence-review/ > **Published:** 2026-03-16T20:11:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:06:28-04:00 > **Clinical Summary:** Explore the latest medicinal cannabis depression anxiety PTSD evidence showing no robust support for its use in these mental health conditions. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchMental HealthSafetyAnxiety Why This Matters Clinicians need this evidence to counsel patients seeking cannabis for mental health conditions, as the lack of robust efficacy data means current prescribing may not be evidence-based and could delay patients from accessing proven treatments like SSRIs or psychotherapy. Patients considering medicinal cannabis for depression, anxiety, or PTSD should understand that current research does not support its use for these conditions, helping them make informed decisions about their [mental health treatment options](https://cedclinic.com/marijuana-use-ptsd-suicidal-risk-military-personnel/). This gap between patient demand and clinical evidence highlights the urgent need for rigorous trials before cannabis becomes standard psychiatric care. Clinical Summary A recent Australian study systematically reviewed evidence for medicinal cannabis efficacy in treating depression, anxiety, and post-traumatic stress disorder, finding insufficient high-quality clinical trial data to support its use for these common psychiatric conditions despite growing patient uptake. While observational reports and patient testimonials suggest potential benefit, the authors emphasize that most supporting evidence comes from preclinical or animal studies rather than rigorous randomized controlled trials in humans, limiting clinicians’ ability to make evidence-based recommendations. The gap between patient demand and available evidence is particularly concerning given that cannabis use carries its own risks, including potential for dependence, cognitive effects, and drug interactions with psychiatric medications. This lack of robust efficacy data contrasts sharply with increasing prescription rates in Australia and other jurisdictions, highlighting a disconnect between clinical practice and the evidence base. Clinicians should be cautious about endorsing medicinal cannabis for depression, anxiety, or PTSD and should counsel patients that current evidence does not support its use for these conditions despite its legal availability in some regions. Until higher-quality randomized trials are completed, established psychotherapeutic and pharmacological treatments remain the standard of care for these psychiatric disorders. Dr. Caplan’s Take “After two decades of prescribing cannabis medicinally, I can tell you that the absence of evidence in randomized trials doesn’t match what I’m seeing in my clinic with certain patients, but it also doesn’t justify prescribing it as first-line treatment for depression or anxiety when we have medications with robust evidence behind them. The honest clinical position is that cannabis may have a role for specific patients who’ve failed conventional therapy or have particular contraindications, but we need to stop implying it’s a proven solution for mood disorders when our best science simply doesn’t support that yet.” Clinical Perspective While medicinal cannabis use for mood and [anxiety disorders](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) is expanding among Australian patients, emerging evidence suggests therapeutic efficacy remains unproven, and clinicians should be cautious about implicit endorsement. The gap between patient demand and robust clinical evidence creates a challenging counseling scenario, particularly given confounding factors such as publication bias favoring positive findings, heterogeneous cannabis formulations with variable cannabinoid profiles, and difficulty isolating psychoactive effects from placebo responses in observational studies. Additionally, potential harms including [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/), [cognitive impairment](https://cedclinic.com/acute-effects-partial-cb1-receptor-agonists-cognition/), and drug interactions with psychiatric medications deserve consideration, yet are often underappreciated in direct-to-consumer marketing and some clinical discussions. Practically, clinicians should acknowledge patient interest in cannabis without recommending it as first-line therapy for depression, anxiety, or PTSD; instead, patients seeking cannabis should be counseled on current evidence limitations, offered established pharmacological and psychotherapeutic 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-related-research/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Does+medicinal+cannabis+work+for+depression%2C+anxiety+or+PTSD%3F+Our+study+says+there%27s+no+evidence+%40drcaplan&url=https%3A%2F%2Ftheconversation.com%2Fdoes-medicinal-cannabis-work-for-depression-anxiety-or-ptsd-our-study-says-theres-no-evidence-278303)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Ftheconversation.com%2Fdoes-medicinal-cannabis-work-for-depression-anxiety-or-ptsd-our-study-says-theres-no-evidence-278303)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Does+medicinal+cannabis+work+for+depression%2C+anxiety+or+PTSD%3F+Our+study+says+there%27s+no+evidence+--+via+%40drcaplan.bsky.social+https%3A%2F%2Ftheconversation.com%2Fdoes-medicinal-cannabis-work-for-depression-anxiety-or-ptsd-our-study-says-theres-no-evidence-278303)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://theconversation.com/does-medicinal-cannabis-work-for-depression-anxiety-or-ptsd-our-study-says-theres-no-evidence-278303](https://theconversation.com/does-medicinal-cannabis-work-for-depression-anxiety-or-ptsd-our-study-says-theres-no-evidence-278303) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [No evidence to suggest medicinal cannabis is effective for depression, anxiety or PTSD](https://cedclinic.com/medicinal-cannabis-mental-health-research-evidence/) A detailed analysis confirming the lack of evidence supporting medicinal cannabis for these mental health conditions. [Read More](https://cedclinic.com/medicinal-cannabis-mental-health-research-evidence/) [Study Finds Little Proof Cannabis Helps Most Mental Health Conditions](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) Research highlighting the limited proof of cannabis efficacy across various [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/). [Explore Study](https://cedclinic.com/cannabis-effectiveness-mental-health-study-limited-evidence/) [Medical cannabis isn't an effective treatment for anxiety, depression or PTSD, new research shows](https://cedclinic.com/medical-cannabis-mental-health-research-evidence/) New research emphasizing the ineffectiveness of medical cannabis for anxiety, depression, and PTSD. [Learn More](https://cedclinic.com/medical-cannabis-mental-health-research-evidence/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).